Target intelligence / Profile preview

Protein PET100 homolog, mitochondrial (PET100)

Target
PET100
Molecular classification
Chaperone, Mitochondrial inner membrane protein, Other (Cytochrome c oxidase assembly factor)
01

Overview

Protein PET100 homolog, mitochondrial (PET100) is a highly conserved mitochondrial chaperone essential for the assembly and stabilization of cytochrome c oxidase (complex IV) of the mitochondrial respiratory chain[1][2][3][5][7]. Localized to the inner mitochondrial membrane and exposed to the intermembrane space, PET100 acts as an assembly factor that coordinates integration of core subunits and ancillary proteins, working together with PET117 and MR-1S to ensure effective complex IV formation. Loss-of-function mutations in PET100 disrupt assembly of complex IV, causing severe mitochondrial disorders such as Leigh syndrome and fatal infantile lactic acidosis, with features of neurodegeneration and impaired energy production[1][5][7][9]. Currently, PET100 is not considered a direct therapeutic target but is important as a disease gene whose mutation results in profound deficiency of mitochondrial electron transport and cellular respiration.

Other names
PET100 cytochrome c oxidase chaperoneC19orf79MC4DN12PET100 homologPET100 mitochondrialprotein PET100 homolog, mitochondrial
02

Mechanism of action

PET100 is not known to be a direct target of drug interventions—it is a chaperone required for cytochrome c oxidase maturation[1][7][9].

03

Biological functions

Assembly and maturation of mitochondrial complex IV (cytochrome c oxidase)Cellular respirationMaintenance of mitochondrial bioenergetic efficiency
04

Disease associations

Mitochondrial complex IV deficiencyLeigh syndromeLactic acidosisNeurodegenerative disease (related to mitochondrial dysfunction)
05

Safety considerations

No direct therapeutic targeting or related safety concerns; mutations result in severe mitochondrial disease, which presents therapeutic challenges rather than safety concerns of targeting the molecule.
06

Biomarkers

PET100 mutations may serve as a genetic biomarker for mitochondrial complex IV deficiencies (e.g., Leigh syndrome)[1][5][9].

Beyond the preview

Go deeper on Protein PET100 homolog, mitochondrial (PET100).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein PET100 homolog, mitochondrial (PET100).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call